|
Workshops: Session III Personalized medicine optimizes healthcare by incorporating pharmacogenomics-based tests into medication selection and dosing recommendations. Although approved tests are available for targeted therapeutics, the challenge remains to achieve clinical uptake. Electronic clinical decision support may drive both the acceptance and adaptation of electronic health records (EHR) systems by providing genetically-informed prescription information at point-of-care. US policymakers, pharmacies, and insurers are addressing the ethical and socio-economical challenges of targeted therapeutics. Presenters: |
Except where otherwise noted, content on this site is
licensed under a Creative Commons Attribution 3.0 License.
Click here to see a list of our funders.
licensed under a Creative Commons Attribution 3.0 License.
Click here to see a list of our funders.
